RABEKYT-D
Focused gastro support for acid suppression and prokinetic care.
Rabeprazole sodium 20 mg + Domperidone Maleate 30 mg SR Capsules
A gastroenterology brand presented as a synergistic combination for acid suppression and prokinetic action.
Explore Kytoger Pharma’s current brand range with clear, responsible product communication across key therapeutic needs.
Kytoger Pharma is building a practical portfolio with emphasis on relevant formulations, dependable communication and responsible positioning across gastroenterology, bone health, nutrition and recovery.
Product information below is presented as brand communication and should be interpreted by qualified healthcare professionals as applicable.
Focused gastro support for acid suppression and prokinetic care.
Rabeprazole sodium 20 mg + Domperidone Maleate 30 mg SR Capsules
A gastroenterology brand presented as a synergistic combination for acid suppression and prokinetic action.
A PPI + prokinetic combination positioned for reflux-oriented care.
Esomeprazole 40 mg + Domperidone 30 mg SR Capsules
A combination brand used in Kytoger communication for hyperacidity, dyspepsia and reflux-oriented physician-led care.
Calcium and vitamin D3 support across important stages of life.
Elemental Calcium 500 mg + Vitamin D3 500 IU Tablets
A calcium and vitamin D3 formulation communicated around maintaining bone health across key stages of life.
A broader micronutrient formulation supporting bone, metabolic and women’s health communication.
Elemental Calcium 500 mg, Vitamin D3 2000 IU, Methylcobalamin 1500 mcg, L-Methylfolate Calcium 1000 mcg, Pyridoxal 5 Phosphate 20 mg Tablets
A multi-nutrient formulation represented across bone and tissue support, metabolic health and women’s health communication.
Proteolytic enzyme support for post-operative, trauma and recovery-oriented care.
Trypsin : Chymotrypsin (6:1) 1,00,000 A.U. Tablets
A proteolytic enzyme brand represented in post-operative, trauma, swelling and recovery-oriented communication.
Our product strategy combines relevant therapeutic categories with clear communication and a growing distribution network. The goal is to build a focused portfolio that healthcare professionals and trade partners can understand and support consistently.